A cancer diagnosis makes diabetes patients less adherent to their prescribed diabetes drugs

Diabetes patients become less adherent to their diabetes medications following a diagnosis of cancer, concludes a new study published in Diabetologia (the journal of the European Association for the Study of Diabetes). The research is led by Marjolein Zanders, Netherlands Comprehensive Cancer Organisation, Eindhoven, the Netherlands, Jeffrey Johnson, School of Public Health, University of Alberta, Edmonton, Canada … Continue reading A cancer diagnosis makes diabetes patients less adherent to their prescribed diabetes drugs

Advertisements

Metformin for breast cancer less effective at higher glucose concentrations

A University of Colorado Cancer Center study published online this month in the journal Cell Cycle shows that breast cancer cell growth, motility and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome. The study also showed that patients with high glucose may require higher doses of the drug metformin to … Continue reading Metformin for breast cancer less effective at higher glucose concentrations